• Wed news: Lilly’s 4.5B medicine foundry project. 5 FDA decisions to watch in Q4. Hurricane Helene and the health supply chain. Lundbeck taps Charles River for AI-enabled neuro drug discovery. Amgen tax evasion lawsuit. See more on our front page

Dilip’s earning release

anonymous

Guest
Man, that was a weak commentary at best!
Including the comment about being pleased with Ilumya? I’m in Opth and even we hear the rumblings that it’s 3+ years in and maybe, just maybe at 1% market share. At this point Sun has sunk 1/2 billion into it. What a joke.
 

<



Man, that was a weak commentary at best!
Including the comment about being pleased with Ilumya? I’m in Opth and even we hear the rumblings that it’s 3+ years in and maybe, just maybe at 1% market share. At this point Sun has sunk 1/2 billion into it. What a joke.
Good to see a couple of butt-kissers give their thumbs up to it on LinkedIn
I’m just curious: if you’re associated with Ilumya, how would you describe your self-esteem ?